课题基金 / 基金详情

Molecular Determinants of Tissue-resident Memory T cell Fate in Acute and Chronic Infection

Molecular Determinants of Tissue-resident Memory T cell Fate in Acute and Chronic Infection
急性和慢性感染中组织驻留记忆 T 细胞命运的分子决定因素
批准号:
10453786
负责人:
Ananda W Goldrath
金额:
$192.62万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-17 至 2024-06-30

项目摘要

项目成果

Ananda W Goldrath的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
OVERALL SUMMARY: Mortality from infectious diseases remains the second leading cause of death worldwide; a further toll on human health is exacted by disease-associated morbidity. The development of new vaccines is, therefore, an important priority for improving global health. Immunological memory is a cardinal feature of adaptive immunity and its induction is the underlying goal of vaccination. Long-lived memory T cells mediate protection from reinfection with previously encountered pathogens; keep chronic, opportunistic and latent pathogens at bay; and can serve as endogenous defenders against tumor growth and metastases. The memory T cell population is heterogeneous, typically categorized into central memory cells found in the blood and lymphoid tissues, or effector memory cells predominantly located in the blood and non-lymphoid tissues. The recent recognition of a third subset of memory lymphocytes, termed tissue-resident memory cells (Trm), that reside strictly within tissues and do not recirculate requires a revision of our understanding of memory T cell differentiation. Tissue- resident T cells provide essential sentinel protection at body surfaces such as the intestinal epithelium, and, are now clearly understood to be among the key `first responders' in many infection settings. Although we now know that resident-memory cells are an essential component of immune memory, little is known about the transcriptional pathways regulating their formation, survival and function. Improving our understanding of these topics will allow us to harness the immediate protective capacity of this vital memory T cell population and modulate activity in the context of immunopathology. To this end, we propose three synergistic projects that all leverage novel single-cell, genomic and computational analyses provided by two Cores to: 1) Define the unanticipated roles of key transcription factors in Trm formation and identify novel molecular determinants of Trm differentiation and homeostasis; 2) Identify early molecular regulators of Trm cell fate specification within different tissues in the context of acute and chronic infections using single-cell analyses of gene expression and computational approaches; 3) Define exhausted Trm during chronic viral infection and identify core regulators that determine their accumulation and hypo-functional state. Understanding the generation and homeostasis of tissue-resident memory cells will allow the exploitation of the immediate protective capacity of this vital memory population and provide strategies to modulate this activity in the context of immunopathology. We have assembled a team of five laboratories, which together possess the tools and expertise to resolve the transcriptional network driving memory T cell formation and exploit this knowledge to realize advances in regulating immunity in tissues. !
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pcbi.1010116
发表时间: 2022-09
期刊: PLoS computational biology
影响因子: 4.3
作者: []
通讯作者:
Ubiquitin ligase regulation of tissue-resident T cell and anti-tumor activity
Regulation of memory T cell differentiation and long-term maintenance
  • 批准号:
    10683278
  • 项目类别:
  • 资助金额:
    $55.53万
  • 财政年份:
    2020
  • 负责人:
    Ananda W Goldrath
  • 依托单位:
Regulation of memory T cell differentiation and long-term maintenance
  • 批准号:
    10591871
  • 项目类别:
  • 资助金额:
    $12.34万
  • 财政年份:
    2020
  • 负责人:
    Ananda W Goldrath
  • 依托单位:
Regulation of memory T cell differentiation and long-term maintenance
  • 批准号:
    10024589
  • 项目类别:
  • 资助金额:
    $50.91万
  • 财政年份:
    2020
  • 负责人:
    Ananda W Goldrath
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究